Cargando…
A high-throughput drug combination screen identifies an anti-glioma synergism between TH588 and PI3K inhibitors
BACKGROUND: Glioblastoma multiforme (GBM) is the most common and lethal type of primary brain tumor. More than half of GBMs contain mutation(s) of PTEN/PI3K/AKT, making inhibitors targeting the PI3K pathway very attractive for clinical investigation. However, so far, PI3K/AKT/mTOR inhibitors have no...
Autores principales: | Chen, Zhen, Chen, Chao, Zhou, Tingting, Duan, Chao, Wang, Qianqian, Zhou, Xiaohui, Zhang, Xia, Wu, Fangrong, Hua, Yunfen, Lin, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376673/ https://www.ncbi.nlm.nih.gov/pubmed/32714096 http://dx.doi.org/10.1186/s12935-020-01427-0 |
Ejemplares similares
-
Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
por: Haas, Bodo, et al.
Publicado: (2018) -
YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
por: Zhou, Shuai, et al.
Publicado: (2021) -
Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021) -
NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling
por: Chen, Yongbing, et al.
Publicado: (2021) -
Induction of H2AX phosphorylation in tumor cells by gossypol acetic acid is mediated by phosphatidylinositol 3-kinase (PI3K) family
por: Guo, Zhong, et al.
Publicado: (2014)